FDA clears Canon USA's new retinal camera
This article was originally published in Clinica
Canon USA's CR-2 digital non-mydriatic retinal camera has received 510(k) clearance from the US FDA. The device, also known as a fundus camera, is used to photograph the inner surface of the eye to help diagnose, monitor or screen for diseases such as glaucoma, retinal detachment or diabetic retinopathy. CR-2 is the firm's lightest camera to date, weighing 15kg, which means it can be installed easily and transported if necessary. In addition, the white LED lamp used in the camera consumes less power than a standard xenon tube and lasts around twice as long, which can help reduce energy costs, the Lake Success, New York firm claims. The CR-2 camera is now available to purchase through Canon dealers.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.